Cardiovascular Comorbidities and Events in  XXXX : Often Underestimated but Worth  Considering.

@entity1 @entity296 @entity5 @entity2294 @entity1149 @entity955 @entity583 @entity204 @entity65
INTRODUCTION: @entity1 with @entity1149 ( @entity1149 ) and @entity65 often share a comparable demographic profile. The aim of this analysis was to assess the significance and prevalence of preexisting CV comorbidity and events in @entity1149 . @entity1 AND METHODS: A total of 715 consecutive @entity1149 @entity1 diagnosed between 2004 and 2009 at the Medical University of Innsbruck were retrospectively assessed regarding CV comorbidities, risk factors, @entity5 treatment, CV events occurring after the start of treatment, and outcome. RESULTS: At least one CV comorbidity was present in 462 (67.2%) of 687 evaluable @entity1 . CV events were documented in 68 @entity1 (9.5%), with conduction disorders being the most prevalent (n  = 19), followed by @entity296 (n  = 13), @entity583 (n  = 13), sudden CV @entity204 (n  = 12), need of revascularization (n  = 6), and @entity2294 (n  = 5). Median time between diagnosis of @entity1149 and CV event was 13.9 months. CV comorbidities and events both showed a direct correlation with increasing age, affecting up to 87.3% and 35.2% of all octogenarians in the study, respectively. The following CV comorbidities were significantly associated with CV events: @entity955 , @entity583 , and @entity296 . Overall survival was not reduced in @entity1 experiencing a CV event compared to @entity1 without an event. CONCLUSION: CV disease and events are frequently observed in @entity1149 @entity1 . To provide definitive recommendations on impact, prevention, and screening of CV disease in @entity1149 , prospective trials are desirable.
